139P HER2+/HR+ breast cancer patients at high risk of relapse derive benefit from extended adjuvant treatment with neratinib: An exploratory analysis from ExteNET study
Cognetti, F., Di Cosimo, S., Bruzzi, P., Caprari, F., Dapretto, E., Trouiller, J-B., Valenti, R., Pronzato, P.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
PNL5 SOCIAL COSTS OF PARKINSON DISEASE IN ITALY
Zecchinelli, A, Caprari, F, Ponzi, P, Bonetti, A, Pezzoli, G
Published in Value in health (01.11.2004)
Published in Value in health (01.11.2004)
Get full text
Journal Article
PCV13 EPIDEMIOLOGY AND COSTS OF ATRIAL TACHYARRHYTMIAS
Diotallevi, P, Occhetta, E, Martinelli, V, Zaccone, G, Ponzi, P, Scivales, A, Caprari, F
Published in Value in health (01.11.2005)
Published in Value in health (01.11.2005)
Get full text
Journal Article
PUK9 ECONOMICAL IMPACT OF SACRAL NERVE STIMULATION THERAPY IN 62 PATIENTS WITH LOWER URINARY TRACT DYSFUNCTION
Cappellano, F, Bertapelle, P, Spreafico, L, del Popolo, G, Kocjancic, E, Donelli, A, Ponzi, P, Giardiello, G, Caprari, F, Catanzaro, F
Published in Value in health (01.11.2003)
Published in Value in health (01.11.2003)
Get full text
Journal Article